Cargando…

Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients

BACKGROUND: To prospectively assess circulating tumor cell (CTC) status at baseline (CTC(BL)) and after one cycle of a new line of systemic therapy (CTC(1C)), and changes from CTC(BL) to CTC(1C) (CTC kinetics, CTC(KIN)) for their utility in predicting response, progression-free (PFS) and overall sur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wallwiener, Markus, Riethdorf, Sabine, Hartkopf, Andreas Daniel, Modugno, Caroline, Nees, Juliane, Madhavan, Dharanija, Sprick, Martin Ronald, Schott, Sarah, Domschke, Christoph, Baccelli, Irène, Schönfisch, Birgitt, Burwinkel, Barbara, Marmé, Frederik, Heil, Jörg, Sohn, Christof, Pantel, Klaus, Trumpp, Andreas, Schneeweiss, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226959/ https://www.ncbi.nlm.nih.gov/pubmed/25015676 http://dx.doi.org/10.1186/1471-2407-14-512

Ejemplares similares

The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients
por: Wallwiener, Markus, et al.
Publicado: (2015)

HER2-targeted therapy influences CTC status in metastatic breast cancer
por: Deutsch, Thomas M., et al.
Publicado: (2020)

Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer
por: Cuk, Katarina, et al.
Publicado: (2013)

How previous treatment changes the metabolomic profile in patients with metastatic breast cancer
por: Nees, Juliane, et al.
Publicado: (2022)

The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast Cancer
por: Stefanovic, Stefan, et al.
Publicado: (2020)

Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer
por: Fischer, Chiara, et al.
Publicado: (2022)

Cut-Off Analysis of CTC Change under Systemic Therapy for Defining Early Therapy Response in Metastatic Breast Cancer
por: Deutsch, Thomas M., et al.
Publicado: (2020)

The evolving concept of cancer and metastasis stem cells
por: Baccelli, Irène, et al.
Publicado: (2012)

Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures
por: Madhavan, Dharanija, et al.
Publicado: (2013)

Fertility preserving management of early endometrial cancer in a patient cohort at the department of women’s health at the university of Tuebingen
por: Andress, Jürgen, et al.
Publicado: (2021)

Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients
por: Baccelli, Irène, et al.
Publicado: (2014)

Circulating miR-200 Family and CTCs in Metastatic Breast Cancer before, during, and after a New Line of Systemic Treatment
por: Fischer, Chiara, et al.
Publicado: (2022)

Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence
por: Cheng, Jie, et al.
Publicado: (2017)

Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer
por: Walter, Vincent, et al.
Publicado: (2020)

Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study
por: Brusniak, Katharina, et al.
Publicado: (2021)

Parity improves anti-tumor immunity in breast cancer patients
por: Krause, Anna-Lena, et al.
Publicado: (2017)

Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial
por: von Au, Alexandra, et al.
Publicado: (2016)

Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistry
por: Stefanovic, Stefan, et al.
Publicado: (2017)

Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control Individuals
por: Cao, Xue, et al.
Publicado: (2018)

Tumor-Free Resection Margin Distance in the Surgical Treatment of Node-Negative Squamous Cell Cancer of the Vulva Has No Impact on Survival: Analysis of a Large Patient Cohort in a Tertiary Care Center
por: Taran, Florin Andrei, et al.
Publicado: (2023)

Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancer
por: von Au, Alexandra, et al.
Publicado: (2022)

Molecular Subtype Conversion between Primary and Metastatic Breast Cancer Corresponding to the Dynamics of Apoptotic and Intact Circulating Tumor Cells
por: Stefanovic, Stefan, et al.
Publicado: (2019)

Impact of mRNA-Assessed Molecular Subtype Conversion, Intact and Apoptotic Circulating Tumor Cells on Survival of Metastatic Breast Cancer Patients: Proof of Principle
por: Stefanovic, Stefan, et al.
Publicado: (2020)

Acceptance of oral chemotherapy in breast cancer patients - a survey study
por: Schott, Sarah, et al.
Publicado: (2011)

Heterogeneity of miR-10b expression in circulating tumor cells
por: Gasch, Christin, et al.
Publicado: (2015)

393 Vancomycin Dosing in Obese Patients
por: Alquwaizani, Mohammed, et al.
Publicado: (2014)

393. Isavuconazole in the Treatment of Coccidioidal Meningitis
por: Heidari, Arash, et al.
Publicado: (2018)

MON-393 Neuroblastoma Masquerading as Pheochromocytoma
por: Sultan, Rahaf, et al.
Publicado: (2019)

Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients
por: Hartkopf, Andreas D, et al.
Publicado: (2017)

The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service
por: Wallwiener, Markus, et al.
Publicado: (2010)

Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program
por: Müller, V., et al.
Publicado: (2021)

DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA
por: Tang, Qiuqiong, et al.
Publicado: (2016)

S393 Bats: important hosts of emerging viruses
por: Calisher, C.
Publicado: (2007)

Expansion and Compression of Time Correlate with Information Processing in an Enumeration Task
por: Wutz, Andreas, et al.
Publicado: (2015)

Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial
por: Wallwiener, Markus, et al.
Publicado: (2017)

Defined Conditions for the Isolation and Expansion of Basal Prostate Progenitor Cells of Mouse and Human Origin
por: Höfner, Thomas, et al.
Publicado: (2015)

A rigorous assessment and comparison of enumeration methods for environmental viruses
por: Kaletta, Judith, et al.
Publicado: (2020)

Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients
por: Riethdorf, Sabine, et al.
Publicado: (2009)

The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy
por: Hartkopf, Andreas Daniel, et al.
Publicado: (2013)

Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial
por: Graf, Joachim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sa9191pjpgmi0ip54fuu53b1f4